National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Antimicrobial (Drug) Resistance
 Understanding Antimicrobial (Drug) Resistance
  Quick Facts
  Definition of Terms
  History
  Causes
  Diagnosis
  Treatment
  Prevention
  A Growing Health Issue
 Research
 Examples of Antimicrobial Resistance


Antimicrobial (Drug) Resistance

Quick Facts

  • Increasing use of antimicrobials in humans, animals, and agriculture has resulted in many microbes developing resistance to these powerful drugs.
  • Many infectious diseases are increasingly difficult to treat because of antimicrobial-resistant organisms, including HIV infection, staphylococcal infection, tuberculosis, influenza, gonorrhea, candida infection, and malaria.
  • Between 5 and 10 percent of all hospital patients develop an infection, leading to an increase of about $5 billion in annual U.S. healthcare costs.
  • About 90,000 of these patients die each year as a result of their infection, up from 13,300 patient deaths in 1992.
  • People infected with antimicrobial-resistant organisms are more likely to have longer hospital stays and may require more complicated treatment.

Volunteer for Clinical Studies

Volunteer for NIAID-funded clinical studies related to antimicrobial (drug) resistance on ClinicalTrials.gov.

Related Links

View a list of links for more information about antimicrobial (drug) resistance.

E-mail Icon E-mail this page
Print Icon Print this page
Plug-ins and Viewers
To open PDFs on this page, download and install the Adobe Acrobat Reader.

Volunteer for Clinical Studies

Volunteer for NIAID-funded clinical studies related to antimicrobial (drug) resistance on ClinicalTrials.gov.

Related Links

View a list of links for more information about antimicrobial (drug) resistance.